IL1B and Parkinson disease: Therefore, pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, as well as anti-inflammatory cytokines such as IL-10, TGF-β, and IL-11, are considered potential biomarkers or therapeutic targets for PD [13].